WHO 'strongly recommends' Pfizer's COVID-19 pill

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

GENEVA: The World Health Organization (WHO) said Friday (Apr 22) it \u0022strongly recommended\u0022 Pfizer\u0027s COVID-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation. However the UN agency warned it was \u0022extremely concerned\u0022 that the inequa

"The medicine can only be administered while the disease is at its early stages," they said.

Yet COVID-19 pills have been seen as a potentially huge step in ending the pandemic as they can be taken at home, rather than in hospital. Remdesivir can be taken within seven days of symptoms setting in, but it is administered intravenously over three days.The WHO called on Pfizer to"make its pricing and deals more transparent" for Paxlovid.

Remdesivir meanwhile costs US$520, Hedman said, but generic versions made by companies in India sell for US$53 to US$64.But earlier this month Pfizer CEO Albert Bourla predicted a bright future for treatments like Paxlovid as people grow tired of getting further booster vaccinations.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines